Illumina Says New HumanOmni Chip 'Important Flagship' for Next Round of GWAS
May 19, 2009
Illumina Says New HumanOmni Chip 'Important Flagship' for Next Round of GWAS
The array is intended to replace the firm's existing 1.2-million feature Human1M-Duo BeadChip as its main offering for researchers conducting genome-wide association studies, CEO Jay Flatley said this week.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NIH Team Presents Findings from Fungi-focused Study of Skin Microbiome
May 22, 2013 / GenomeWeb Daily News - Researchers ID Colorectal Cancer Subtypes through Expression Profiling; Prognostic Value Noted
May 22, 2013 / GenomeWeb Daily News - At Investor Confab, Illumina Details 'Enormous' DTC Demand as Market Shifts to Less Complex Chips
May 21, 2013 / BioArray News - ICCG, Awaiting Funding, Moves Ahead with Plans to Build Database of Genomic, Phenotypic Information
May 21, 2013 / BioArray News - Q&A: INMEGEN's Alfredo Hidalgo on Using Genomics to Address Mexico's Most Pressing Health Problems
May 21, 2013 / BioArray News